Mobix Labs is trading at $1.15, up 23.57%, after announcing an initial F-16 component order on September 8.
- The defense-related contract expands its U.S. fighter-aircraft footprint and is the clearest company-specific catalyst behind the gain.
- The move reverses recent weakness after shares closed at $0.93 on September 4.
- Broader U.S. markets were slightly lower, making marketwide strength an unlikely explanation.